Filter
100
Filtered Results: 100
Text search:
R.
Baggaley
et
al.
Featured
Recommendations
5
New Publications
14
Language
Document type
No document type
43
Guidelines
31
Studies & Reports
22
Fact sheets
2
Manuals
1
Strategic & Response Plan
1
Countries / Regions
Global
4
Kenya
3
Africa
3
Russia
3
Ukraine
2
Malawi
2
Eastern Europe
2
Zambia
2
Myanmar / Burma
2
North Macedonia
1
Burkina Faso
1
Armenia
1
Belgium
1
Spain
1
Belarus
1
East and Southern Africa
1
Namibia
1
Georgia
1
Ethiopia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
13
Countries
12
Public Health
4
Women & Child Health
3
Key Resources
2
Capacity Building
1
Pharmacy & Technologies
1
Toolboxes
HIV
64
TB
8
Mental Health
2
NTDs
2
Rapid Response
1
Refugee
1
Ebola & Marburg
1
COVID-19
1
Caregiver
1
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Circumcision – consultative review of additional information, 12 August 2016
21 September 2016
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, base...
Module 2
Community Educators and Advocates
July 2017
Module 2: Community educators and advocates. Community educators and advocates are needed to increase awareness about PrEP in their communities. This module provides information on PrEP that should be considered in community-led activities ...
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
Module 12:
Adolescents and young adults
July 2018
Module 12: Adolescents and young adults. This module is for people who are interested in providing PrEP services to older adolescents and young adults who are at substantial risk for HIV. It provides information on: factors that influence HIV...
Almost half (46%) of the world’s 1.7 million children living with HIV were not on treatment in 2020 and 150 000 children were newly infected with HIV, four times more than the 2020 target of 40 000
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
The Millennium Development Goals (MDGs) showed
that global commitment and collective action
could significantly reduce the disease burdens of
three deadly communicable diseases: HIV/AIDS,
tuberculosis (TB) and malaria. The MDGs helped
focus efforts on these three deadly diseases
and leveraged ...
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care, ...
This publication provides managers with guidance on how to create basic HIV prevention cascades as a starting point to enhance their ability to monitor and improve their programming and to facilitate comparisons of programme effectiveness across sites.
Technical Brief
July 2017
Module 1
Clinical
July 2017
Module 1: Clinical. This module is for clinicians, including physicians, nurses and clinical officers. It gives an overview of how to provide PrEP safely and effectively, including: screening for substantial risk of HIV; performing appropriate testing before initi...
Module 6
Pharmacists
July 2017
Module 6: Pharmacists. This module is for pharmacists and people working in pharmacies. It provides information on the medicines used in PrEP, including on storage conditions. It gives suggestions for how pharmacists and pharmacy staff can monitor PrEP adherence...
For the global community to be able to achieve ambitious targets relating to the prevention and treatment of HIV, viral hepatitis and sexually transmitted infections (STIs), multiple types of medicines must be widely accessible to all affected populations in all countries.
The purpose of this rep...
Accessed: 27.11.2019
A Cost-Efficiency Analysis for the Kyrgyz Republi
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
